676.77
price up icon1.13%   7.575
 
loading
前日終値:
$669.20
開ける:
$671.46
24時間の取引高:
306.54K
Relative Volume:
0.70
時価総額:
$18.93B
収益:
$2.68B
当期純損益:
$460.40M
株価収益率:
42.57
EPS:
15.8963
ネットキャッシュフロー:
$711.00M
1週間 パフォーマンス:
+8.73%
1か月 パフォーマンス:
+9.35%
6か月 パフォーマンス:
+60.61%
1年 パフォーマンス:
+13.46%
1日の値動き範囲:
Value
$0.00
$0.00
1週間の範囲:
Value
$614.98
$684.52
52週間の値動き範囲:
Value
$373.00
$684.52

Medpace Holdings Inc Stock (MEDP) Company Profile

Name
名前
Medpace Holdings Inc
Name
セクター
Healthcare (1053)
Name
電話
(513) 579-9911
Name
住所
5375 MEDPACE WAY, CINCINNATI, OH
Name
職員
6,200
Name
Twitter
@WorkatMedpace
Name
次回の収益日
null
Name
最新のSEC提出書
Name
MEDP's Discussions on Twitter

Compare MEDP vs TMO, DHR, NTRA, A, IQV

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
MEDP icon
MEDP
Medpace Holdings Inc
676.77 18.93B 2.68B 460.40M 711.00M 15.90
TMO icon
TMO
Thermo Fisher Scientific Inc
684.89 253.24B 45.20B 6.87B 6.75B 18.19
DHR icon
DHR
Danaher Corp
232.97 163.77B 24.78B 3.68B 5.29B 5.1743
NTRA icon
NTRA
Natera Inc
404.90 58.36B 2.50B -226.32M 71.51M -1.6412
A icon
A
Agilent Technologies Inc
175.96 49.61B 7.23B 1.41B 1.09B 4.979
IQV icon
IQV
Iqvia Holdings Inc
273.60 45.03B 16.63B 1.39B 2.12B 8.0674

Medpace Holdings Inc Stock (MEDP) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-09-30 再開されました UBS Neutral
2026-07-08 ダウングレード Robert W. Baird Outperform → Neutral
2026-07-07 ダウングレード Jefferies Buy → Hold
2026-03-06 アップグレード Barclays Underweight → Equal Weight
2026-03-03 開始されました RBC Capital Mkts Outperform
2026-02-18 アップグレード TD Cowen Sell → Hold
2026-02-13 アップグレード Jefferies Hold → Buy
2026-02-10 アップグレード Robert W. Baird Neutral → Outperform
2025-11-13 開始されました BMO Capital Markets Market Perform
2025-10-02 ダウングレード Barclays Equal Weight → Underweight
2025-09-03 ダウングレード Rothschild & Co Redburn Buy → Neutral
2025-07-29 ダウングレード UBS Neutral → Sell
2025-07-23 ダウングレード TD Cowen Hold → Sell
2025-06-24 開始されました Barclays Equal Weight
2025-04-22 ダウングレード William Blair Outperform → Mkt Perform
2025-04-14 ダウングレード TD Cowen Buy → Hold
2025-03-24 開始されました Leerink Partners Market Perform
2024-10-23 ダウングレード Robert W. Baird Outperform → Neutral
2024-10-14 開始されました Redburn Atlantic Buy
2024-09-27 ダウングレード UBS Buy → Neutral
2024-09-25 ダウングレード Jefferies Buy → Hold
2024-08-01 開始されました Truist Hold
2024-05-29 開始されました TD Cowen Buy
2024-05-28 開始されました Mizuho Buy
2024-04-23 アップグレード Jefferies Hold → Buy
2024-03-18 開始されました Deutsche Bank Hold
2024-02-15 アップグレード UBS Neutral → Buy
2023-10-24 アップグレード Robert W. Baird Neutral → Outperform
2023-05-08 アップグレード Guggenheim Neutral → Buy
2022-10-27 アップグレード UBS Sell → Neutral
2022-09-07 開始されました UBS Sell
2022-05-24 開始されました Guggenheim Neutral
2021-08-05 再開されました Credit Suisse Outperform
2020-10-02 アップグレード Truist Hold → Buy
2020-06-08 アップグレード Robert W. Baird Underperform → Neutral
2020-05-13 ダウングレード Wolfe Research Outperform → Peer Perform
2020-04-30 アップグレード SunTrust Sell → Hold
2020-04-20 ダウングレード Robert W. Baird Neutral → Underperform
2020-03-17 ダウングレード SunTrust Hold → Sell
2020-01-27 ダウングレード SunTrust Buy → Hold
2018-10-31 アップグレード SunTrust Hold → Buy
2018-09-17 開始されました SunTrust Hold
2018-07-31 アップグレード William Blair Mkt Perform → Outperform
2017-11-01 ダウングレード William Blair Outperform → Mkt Perform
2017-09-29 開始されました Raymond James Mkt Perform
2017-07-10 ダウングレード KeyBanc Capital Mkts Overweight → Sector Weight
すべてを表示

Medpace Holdings Inc (MEDP) 最新ニュース

pulisher
Oct 26, 2026

Is Medpace (MEDP) a Solid Growth Stock? 3 Reasons to Think "Yes" - Zacks Investment Research

Oct 26, 2026
pulisher
Oct 26, 2026

All You Need to Know About Medpace (MEDP) Rating Upgrade to Buy - Zacks Investment Research

Oct 26, 2026
pulisher
Oct 22, 2026

Medpace: 3 Key Takeaways for Long-Term Investors - The Motley Fool

Oct 22, 2026
pulisher
Oct 21, 2026

Medpace (MEDP) Q3 Earnings and Revenues Beat Estimates - Zacks Investment Research

Oct 21, 2026
pulisher
Oct 14, 2026

Form 4 Medpace Holdings Inc: Susan E. Burwig (Exec. VP, Operations) For: 12 October - Investing.com Canada

Oct 14, 2026
pulisher
Oct 14, 2026

Form 4 Medpace Holdings Inc: Susan E. Burwig (Exec. VP, Operations) For: 12 October - Investing.com UK

Oct 14, 2026
pulisher
Oct 14, 2026

At $166.73 a share, Medpace (MEDP) EVP Susan E. Burwig exercised options for 3,000 shares. - Stock Titan

Oct 14, 2026
pulisher
Oct 14, 2026

CON vs. MEDP: Which Stock Should Value Investors Buy Now? - Zacks Investment Research

Oct 14, 2026
pulisher
Oct 13, 2026

Medpace (MEDP) Dips More Than Broader Market: What You Should Know - Zacks Investment Research

Oct 13, 2026
pulisher
Oct 09, 2026

At $166.73 per share, Medpace (MEDP) EVP Susan E. Burwig exercises options for 2,000 shares. - Stock Titan

Oct 09, 2026
pulisher
Oct 06, 2026

Medpace (MEDP) Stock Declines While Market Improves: Some Information for Investors - Zacks Investment Research

Oct 06, 2026
pulisher
Oct 02, 2026

After converting stock units into 28 shares, Medpace (MEDP) director McCarthy holds 12,303 shares directly. - Stock Titan

Oct 02, 2026
pulisher
Oct 02, 2026

After a 32-share grant conversion, Medpace (MEDP) director Kraft holds 987 shares directly. - Stock Titan

Oct 02, 2026
pulisher
Oct 02, 2026

After a 36-share conversion, Medpace (MEDP) director Carley holds 27,861 common shares. - Stock Titan

Oct 02, 2026
pulisher
Oct 02, 2026

Medpace Holdings CEO August Troendle sells $30.3m in stock By Investing.com - Investing.com South Africa

Oct 02, 2026
pulisher
Oct 02, 2026

Medpace Holdings CEO August Troendle sells $30.3m in stock By Investing.com - Investing.com Nigeria

Oct 02, 2026
pulisher
Oct 02, 2026

Form 4 Medpace Holdings Inc For: 2 October By Investing.com - Investing.com Nigeria

Oct 02, 2026
pulisher
Oct 02, 2026

Form 4 Medpace Holdings Inc For: 2 October By Investing.com - Investing.com South Africa

Oct 02, 2026
pulisher
Oct 02, 2026

Medpace Holdings CEO August Troendle sells $30.3m in stock - Investing.com

Oct 02, 2026
pulisher
Oct 02, 2026

Form 4 Medpace Holdings Inc For: 2 October By Investing.com - Investing.com Australia

Oct 02, 2026
pulisher
Sep 30, 2026

Two days of CEO share sales at Medpace (MEDP) were executed through an open-window limit order. - Stock Titan

Sep 30, 2026
pulisher
Sep 29, 2026

Medpace (MEDP) Rises As Market Takes a Dip: Key Facts - Zacks Investment Research

Sep 29, 2026
pulisher
Sep 29, 2026

At about $620 a share, Medpace (MEDP) CEO sells stock on two dates: 2,410 shares and 154 shares - Stock Titan

Sep 29, 2026
pulisher
Sep 28, 2026

Form 13D/A Medpace Holdings For: 28 September By Investing.com - Investing.com Nigeria

Sep 28, 2026
pulisher
Sep 27, 2026

Medpace Holdings CEO August J. Troendle sells $6.75m in stock - Investing.com

Sep 27, 2026
pulisher
Sep 27, 2026

Medpace Holdings CEO August Troendle sells $44.4m stock - Investing.com

Sep 27, 2026
pulisher
Sep 27, 2026

Form 4 Medpace Holdings Inc For: 27 September By Investing.com - Investing.com India

Sep 27, 2026
pulisher
Sep 27, 2026

Form 4 Medpace Holdings Inc For: 27 September By Investing.com - Investing.com UK

Sep 27, 2026
pulisher
Sep 25, 2026

CEO sells shares on two days at Medpace (MEDP); a separate entry lists 4,733,019 indirectly held shares. - Stock Titan

Sep 25, 2026
pulisher
Sep 24, 2026

After a 13,059-share sale, August Troendle reports a stake in Medpace (MEDP). - Stock Titan

Sep 24, 2026
pulisher
Sep 23, 2026

Medpace (MEDP) CEO sold 49,018 shares on Sept. 22 at a $628.11 average price. - Stock Titan

Sep 23, 2026
pulisher
Sep 23, 2026

MEDP FINAL DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Medpace Holdings, Inc. Investors to Secure Counsel Before Important June 8 Deadline in Securities Class ActionMEDP - TMX Newsfile

Sep 23, 2026
pulisher
Sep 22, 2026

MEDP DEADLINE ALERT: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Medpace Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 8 Deadline in Securities Class ActionMEDP - TMX Newsfile

Sep 22, 2026
pulisher
Sep 21, 2026

Medpace (MEDP) Outperforms Broader Market: What You Need to Know - Zacks Investment Research

Sep 21, 2026
pulisher
Sep 21, 2026

Medpace (NASDAQ: MEDP) CEO sells shares, holds 504,273 directly - stocktitan.net

Sep 21, 2026
pulisher
Sep 18, 2026

Medpace Holdings, Inc.Common Stock (Nasdaq:MEDP) Price Chart - The Chronicle-Journal

Sep 18, 2026
pulisher
Sep 17, 2026

Medpace Holdings (MEDP) CEO sells stock in two $620-range trades - stocktitan.net

Sep 17, 2026
pulisher
Sep 17, 2026

Medpace Holdings (MEDP) insider exercises 3,000 options - stocktitan.net

Sep 17, 2026
pulisher
Sep 11, 2026

Here’s How Much You Would Have Made Owning Medpace Holdings Stock In The Last 5 Years - Benzinga

Sep 11, 2026
pulisher
Sep 10, 2026

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Medpace Holdings, Inc. (MEDP) And Encourages Shareholders to Reach Out - ACCESS Newswire

Sep 10, 2026
pulisher
Sep 07, 2026

Medpace Holdings, Inc. (MEDP) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Sep 07, 2026
pulisher
Sep 07, 2026

Medpace Holdings, Inc. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsMEDP - Eastern Progress

Sep 07, 2026
pulisher
Sep 07, 2026

MEDP Investor Alert: Medpace Holdings Inc. Securities Fraud LawsuitInvestors With Losses May Seek to Lead the Class Action After President Allegedly Oversaw Misleading Disclosures: Levi & Korsinsky - Eastern Progress

Sep 07, 2026
pulisher
Sep 07, 2026

Medpace Holdings, Inc. (MEDP) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - Eastern Progress

Sep 07, 2026
pulisher
Sep 07, 2026

Medpace Deadline: MEDP Investors with Losses in Excess of $100K Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit - Eastern Progress

Sep 07, 2026
pulisher
Sep 07, 2026

Medpace Holdings, Inc. (MEDP) Stock Analysis: Evaluating the Healthcare Giant’s Growth Potential - DirectorsTalk Interviews

Sep 07, 2026
pulisher
Sep 07, 2026

MEDP Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Medpace Holdings, Inc. Securities LawsuitContact The Gross Law Firm - Eastern Progress

Sep 07, 2026
pulisher
Sep 04, 2026

Bronstein, Gewirtz & Grossman, LLC Encourages Medpace Holdings, Inc. (MEDP) Stockholders to Inquire about Securities Investigation - ACCESS Newswire

Sep 04, 2026
pulisher
Sep 04, 2026

Medpace Holdings Inc. (MEDP) Key Financial Ratios – Valuation, Profitability & More - Value Research

Sep 04, 2026
pulisher
Sep 01, 2026

Medpace Holdings, Inc. (MEDP), Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - accessnewswire.com

Sep 01, 2026

Medpace Holdings Inc (MEDP) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Medpace Holdings Inc (MEDP) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
BURWIG SUSAN E
Exec. VP, Operations
Oct 21 '26
Option Exercise
166.73
2,700
450,171
73,684
BURWIG SUSAN E
Exec. VP, Operations
Oct 12 '26
Option Exercise
166.73
3,000
500,190
70,984
BURWIG SUSAN E
Exec. VP, Operations
Oct 07 '26
Option Exercise
166.73
2,000
333,460
67,984
Troendle August J.
President & CEO
Sep 30 '26
Sale
625.47
21,966
13,739,074
338,225
Troendle August J.
President & CEO
Sep 29 '26
Sale
621.02
26,701
16,581,855
360,191
Troendle August J.
President & CEO
Sep 28 '26
Sale
620.07
2,410
1,494,369
386,892
Troendle August J.
President & CEO
Sep 25 '26
Sale
620.60
154
95,572
389,302
Troendle August J.
President & CEO
Sep 24 '26
Sale
621.33
27,833
17,293,478
389,456
Troendle August J.
President & CEO
Sep 23 '26
Sale
628.64
16,083
10,110,417
417,289
Troendle August J.
President & CEO
Sep 22 '26
Sale
628.11
49,018
30,788,696
433,372
$160.39
price up icon 1.02%
CRL CRL
$357.27
price up icon 3.45%
GH GH
$173.25
price up icon 2.47%
$183.78
price down icon 0.80%
LH LH
$329.90
price up icon 0.29%
DGX DGX
$242.95
price up icon 0.44%
大文字化:     |  ボリューム (24 時間):